The project described above is listed on the WADA website (here in PDF) and was funded for the period 2013-2014 (according to a research report of the University of Otago Heath Sciences department here in PDF). Colvert was sanctioned in 2014.
Here is a key passage:
Reliable, sensitive and specific measurement of the hormone EPO + related analogues, used to illegally enhance sports performance, is a continuing problem for WADA. To date, immunoassay tests for EPO suffer sensitivity and specificity problems due to the multiple forms of EPO normally present in blood and also from newer synthetic short forms that can be used by competitive athletes.Sensitivity refers to false negatives (dopers who escape detection) and specificity refers to false positives (innocent athletes wrongly accused).